Table 3 Subgroup analysis of fish oil consumption and insulin sensitivity
From: Fish oil supplementation and insulin sensitivity: a systematic review and meta-analysis
Subgroup | No. Of studies | SMD (95%IC) | P value | I2 value (%) |
|---|---|---|---|---|
Methods of insulin sensitivity | ||||
Clamps | 4 | 0.10(−0.18–0.44) | 0.41 | 0.00 |
HOMA | 9 | 0.28(−0.08–0.63) | 0.13 | 66.6 |
QUICKI | 3 | 0.15(−0.68–0.97) | 0.73 | 81.6 |
Glucose tolerance | 1 | 0.19(−0.05–0.42) | 0.79 | 58.1 |
Population | ||||
T2DM | 8 | 0.12(−0.22–0.45) | 0.50 | 57.1 |
Metabolic disorders | 5 | 0.53(0.17–0.88) | <0.001 | 42.6 |
Healthy people | 4 | -0.15(−0.53–0.24) | 0.46 | 22.8 |
Dose | ||||
≥2 g | 14 | 0.17(−0.11–0.46) | 0.24 | 64.2 |
< 2 g | 3 | 0.26(−0.04–0.56) | 0.09 | 0.00 |
Duration | ||||
≥12w | 9 | 0.09(−0.25–0.44) | 0.60 | 70.2 |
<12w | 8 | 0.31(−0.01–0.61) | 0.04 | 29.4 |